Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis

Journal of Virology

Volumn 87, Issue 1, 2013, Pages 581-596

  Webster, Brian ^a   Wissing, Silke ^a   Herker, Eva ^a,c   Ott, Melanie ^a,b   Greene, Warner C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; COMPETITIVE ABILITY; CONTROLLED STUDY; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; INTRACELLULAR SIGNALING; MITOSIS; NONHUMAN; PRIORITY JOURNAL; REPLICON; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MITOSIS; VIRAL INTERFERENCE;

HEPATITIS C VIRUS;

EID: 84871993454     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01047-12     Document Type: Article

References (75)

1. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
2. Flamm SL. 2003. Chronic hepatitis C virus infection. JAMA 289:2413-2417.
3. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
4. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
5. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.
6. Kato T, Furusaka A, Miyamoto M, Date T, Yasui K, Hiramoto J, Nagayama K, Tanaka T, Wakita T. 2001. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64:334-339.
7. Bartenschlager R, Sparacio S. 2007. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res. 127: 195-207.
8. Dentzer TG, Lorenz IC, Evans MJ, Rice CM. 2009. Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus. J. Virol. 83:12702-12713.
9. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, Knudsen ML, Hoegh AM, Bukh J. 2009. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364-377.
10. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103:7408-7413.
11. Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2007. Analysis of hepatitis C virus super-infection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81:4591-4603.
12. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM. 2007. Superinfection exclusion in cells infected with hepatitis C virus. J. Virol. 81:3693-3703.
13. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76: 13001-13014.
14. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T. 2006. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1:2334-2339.
15. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
16. Sainz B, Jr, Chisari FV. 2006. Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J. Virol. 80:10253-10257.
17. Parsley TB, Chen B, Geletka LM, Nuss DL. 2002. Differential modulation of cellular signaling pathways by mild and severe hypovirus strains. Eukaryot. Cell 1:401-413.
18. Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE, Goff SP, Lindenbach BD, Rice CM. 2004. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78:7400-7409.
19. Appel N, Herian U, Bartenschlager R. 2005. Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. J. Virol. 79:896-909.
20. Evans MJ, Rice CM, Goff SP. 2004. Genetic interactions between hepatitis C virus replicons. J. Virol. 78:12085-12089.
21. Deng L, Adachi T, Kitayama K, Bungyoku Y, Kitazawa S, Ishido S, Shoji I, Hotta H. 2008. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J. Virol. 82:10375-10385.
22. Mateu G, Donis RO, Wakita T, Bukh J, Grakoui A. 2008. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology 376:397-407.
23. Blackham S, Baillie A, Al-Hababi F, Remlinger K, You S, Hamatake R, McGarvey MJ. 2010. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J. Virol. 84:5404-5414.
24. Walters KA, Syder AJ, Lederer SL, Diamond DL, Paeper B, Rice CM, Katze MG. 2009. Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog. 5:e1000269. doi:10.1371/journal.ppat.1000269.
25. van Engeland M, Ramaekers FCS, Schutte B, Reutelingsperger CPM. 1996. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24:131-139.
26. Kannan RP, Hensley LL, Evers LE, Lemon SM, McGivern DR. 2011. Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J. Virol. 85:7989-8001.
27. Lu L, Ladinsky MS, Kirchhausen T. 2009. Cisternal organization of the endoplasmic reticulum during mitosis. Mol. Biol. Cell 20:3471-3480.
28. Puhka M, Vihinen H, Joensuu M, Jokitalo E. 2007. Endoplasmic reticulum remains continuous and undergoes sheet-to-tubule transformation during cell division in mammalian cells. J. Cell Biol. 179:895-909.
29. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, Imamura T, Ogawa M, Masai H, Miyawaki A. 2008. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132:487-498.
30. Tada S. 2007. Cdt1 and geminin: role during cell cycle progression and DNA damage in higher eukaryotes. Front. Biosci. 12:1629-1641.
31. Edwards CT, Holmes EC, Wilson DJ, Viscidi RP, Abrams EJ, Phillips RE, Drummond AJ. 2006. Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol. Biol. 6:28. doi:10.1186/1471-2148-6-28.
32. Wahl LM, Gerrish PJ. 2001. The probability that beneficial mutations are lost in populations with periodic bottlenecks. Evolution 55:2606-2610. 33. Hartl DL, Clark AG. 1997. Principles of population genetics, 3rd ed. Sinauer Associates, Sunderland, MA.
33. Hartl DL Clark AG. 1997. Principles of population genetics, 3rd ed. Sinauer Associates, Sunderland, MA.
34. Kimura M, Ohta T. 1969. The average number of generations until fixation of a mutant gene in a finite population. Genetics 61:763-771.
35. Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K. 2002. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76:5974-5984.
36. Lindenbach BD. 2011. Understanding how hepatitis C virus builds its unctuous home. Cell Host Microbe 9:1-2.
37. Sklan EH, Glenn JS. 2006. HCV NS4B: from obscurity to central stage, p 245-266. In Tan SL (ed), Hepatitis C viruses: genomes and molecular biology. Horizon Bioscience, Norfolk, United Kingdom.
38. Grassmann CW, Isken O, Tautz N, Behrens SE. 2001. Genetic analysis of the pestivirus nonstructural coding region: defects in the NS5A unit can be complemented in trans. J. Virol. 75:7791-7802.
39. Fridell RA, Qiu D, Valera L, Wang C, Rose RE, Gao M. 2011. Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052. J. Virol. 85:7312-7320.
40. Jones DM, Patel AH, Targett-Adams P, McLauchlan J. 2009. The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J. Virol. 83:2163-2177.
41. Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi MR, Pedrazzini E, Bonatti S, Migliaccio G. 2002. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293:31-43.
42. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM. 2004. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324:450-461.
43. Gao L, Aizaki H, He JW, Lai MM. 2004. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J. Virol. 78: 3480-3488.
44. Mannova P, Fang R, Wang H, Deng B, McIntosh MW, Hanash SM, Beretta L. 2006. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol. Cell. Proteomics 5:2319-2325.
45. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77:4160-4168.
46. Heng YW, Koh CG. 2010. Actin cytoskeleton dynamics and the cell division cycle. Int. J. Biochem. Cell Biol. 42:1622-1633.
47. Bost AG, Venable D, Liu L, Heinz BA. 2003. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J. Virol. 77:4401-4408.
48. Lai CK, Jeng KS, Machida K, Lai MM. 2008. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J. Virol. 82:8838-8848.
49. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83:2011-2014.
50. Sainz B, Jr, Barretto N, Martin DN, Hiraga N, Imamura M, Hussain S, Marsh KA, Yu X, Chayama K, Alrefai WA, Uprichard SL. 2012. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 18:281-285.
51. Reynolds GM, Harris HJ, Jennings A, Hu K, Grove J, Lalor PF, Adams DH, Balfe P, Hubscher SG, McKeating JA. 2008. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47: 418-427.
52. Nakamuta M, Fujino T, Yada R, Aoyagi Y, Yasutake K, Kohjima M, Fukuizumi K, Yoshimoto T, Harada N, Yada M, Kato M, Kotoh K, Taketomi A, Maehara Y, Nakashima M, Enjoji M. 2011. Expression profiles of genes associated with viral entry in HCV-infected human liver. J. Med. Virol. 83:921-927.
53. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. 2003. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J. Virol. 77:3007-3019.
54. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. 2006. Absence of HCV viral recombination following superinfection. J. Viral Hepat. 13:532-537.
55. Blackard JT, Sherman KE. 2007. Hepatitis C virus coinfection and superinfection. J. Infect. Dis. 195:519-524.
56. Zhou Y, Wang X, Hong G, Tan Z, Zhu Y, Lan L, Mao Q. 2010. Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures. J. Clin. Virol. 49:272-276.
57. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, Romero H, Khan B, Cristina J. 2004. Evidence of intratypic recombination in natural populations of hepatitis C virus. J. Gen. Virol. 85:31-37.
58. Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, Abellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J. Med. Virol. 78:1423-1428.
59. Kurbanov F, Tanaka Y, Avazova D, Khan A, Sugauchi F, Kan N, Kurbanova-Khudayberganova D, Khikmatullaeva A, Musabaev E, Mizokami M. 2008. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol. Res. 38:457-464.
60. Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Pasquier C, Izopet J. 2007. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J. Virol. 81:4357-4362.
61. Moreno P, Alvarez M, Lopez L, Moratorio G, Casane D, Castells M, Castro S, Cristina J, Colina R. 2009. Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient. Virol. J. 6:203.
62. Kao JH, Chen PJ, Lai MY, Yang PM, Sheu JC, Wang TH, Chen DS. 1994. Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis. J. Infect. Dis. 170:1128-1133.
63. Ramirez S, Perez-del-Pulgar S, Carrion JA, Coto-Llerena M, Mensa L, Dragun J, Garcia-Valdecasas JC, Navasa M, Forns X. 2010. Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains. J. Gen. Virol. 91:1183-1188.
64. Nelson HB, Tang H. 2006. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J. Virol. 80:1181-1190.
65. Scholle F, Li K, Bodola F, Ikeda M, Luxon BA, Lemon SM. 2004. Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J. Virol. 78:1513-1524.
66. Kronenberger B, Ruster B, Lee JH, Sarrazin C, Roth WK, Herrmann G, Zeuzem S. 2000. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J. Hepatol. 33:640-647.
67. Wilfredo Canchis P, Gonzalez SA, Isabel Fiel M, Chiriboga L, Yee H, Edlin BR, Jacobson IM, Talal AH. 2004. Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein. Liver Int. 24:198-203.
68. Kung JW, Currie IS, Forbes SJ, Ross JA. 2010. Liver development, regeneration, and carcinogenesis. J. Biomed. Biotechnol. 2010:984248. doi:10.1155/2010/984248.
69. Levrero M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847.
70. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W. 1996. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23:1468-1475.
71. Freeman A, Hamid S, Morris L, Vowler S, Rushbrook S, Wight DG, Coleman N, Alexander GJ. 2003. Improved detection of hepatocyte proliferation using antibody to the pre-replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection. J. Viral Hepat. 10:345-350.
72. Lake-Bakaar G, Mazzoccoli V, Ruffini L. 2002. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virusrelated chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig. Dis. Sci. 47:1644-1648.
73. Sarfraz S, Hamid S, Ali S, Jafri W, Siddiqui AA. 2009. Modulations of cell cycle checkpoints during HCV associated disease. BMC Infect. Dis. 9:125. doi:10.1186/1471-2334-9-125.
74. Matsuoka M, Tani K, Asano S. 1998. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages. Oncogene 16:2075-2086.
75. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grander D. 1999. Molecular mechanisms underlying interferon-alphainduced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 18:2798-2810.